Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Central retinal vein occlusion

R Spires

    Journal of Ophthalmic Nursing & Technology
    |March 1, 1993
    PubMed
    Summary

    Central retinal vein occlusion (CRVO) presents as ischemic or nonischemic types. Differentiating these CRVO types is crucial for effective management and preventing complications like neovascularization.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The ophthalmic ambulatory surgery patient.

    Journal of post anesthesia nursing·1996
    Same author

    Contact Laser transscleral cyclophotocoagulation in the treatment of glaucoma.

    Journal of ophthalmic nursing & technology·1995
    Same author

    Aspergillus-induced endophthalmitis.

    Journal of ophthalmic nursing & technology·1995
    Same author

    Ocular manifestations of sickle cell disease.

    Journal of ophthalmic nursing & technology·1995
    Same author

    Traumatic hyphema (continuing education credit).

    Journal of ophthalmic nursing & technology·1995
    Same author

    Pediatric pseudotumor cerebri.

    Journal of ophthalmic nursing & technology·1994

    Area of Science:

    • Ophthalmology
    • Vascular Medicine

    Background:

    • Central retinal vein occlusion (CRVO) is a significant cause of vision loss.
    • CRVO is broadly classified into ischemic and nonischemic subtypes.

    Observation:

    • Retinal capillary obliteration is a key indicator of retinal ischemia in CRVO.
    • Fluorescein fundus angiography is essential for distinguishing between ischemic and nonischemic CRVO.
    • A relative afferent pupillary defect (RAPD) aids in differentiating CRVO types during all disease stages.

    Findings:

    • Ischemic CRVO exhibits marked retinal capillary obliteration, unlike the nonischemic type.
    • Hemorrhagic retinopathy is associated with a positive RAPD, indicative of the ischemic form.
    • Ocular neovascularization represents the most severe complication of CRVO.

    Implications:

    • Accurate CRVO classification impacts treatment strategies and prognosis.
    • Early detection of ischemic CRVO via angiography and RAPD testing is vital.
    • Understanding CRVO subtypes helps in managing and preventing sight-threatening complications such as neovascularization.

    Related Experiment Videos